Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGAH.L Regulatory News (GAH)

  • There is currently no data for GAH

Trading Update

31 Mar 2016 07:00

RNS Number : 6048T
Gable Holdings Inc
31 March 2016
 

31 March, 2016

Gable Holdings Inc.

Trading Update

Further to the statement made on 21 December 2015, Gable Holdings Inc. ("Gable" or the "Company") today provides a trading update for the 12 month period ended 31 December 2015.

 

Summary

§ Gross Written Premiums of over £100m, representing a 25% increase over the prior period

§ High retention rates and new referrals continue to drive strong growth in underlying business across all European markets

§ Over 40% increase in cash and liquid investment balances to £60m

§ Pre-tax loss for the group expected to be between £7 million and £8 million after taking into account:

o Previously announced £7.5 million provision to eliminate the remaining balance of the pre-2012 historical reserving gap;

o The cost of the Quota Share agreement as announced in December 2015; and

o Provisions for claims arising from the significant floods experienced in the UK and Europe in December 2015, the impact of which is limited to between £2 million and £3 million through reinsurance arrangements 

§ The Company's Loan Note Instrument is closed with immediate effect and no further Loan Notes will be issued. The funding provided by the instrument ensured compliance with current solvency requirements under the transitional provisions of Solvency II, utilised by the Company and many other insurers across Europe. The transitional provisions set out in European Directives (and encompassed within Liechtenstein Law) give an insurer until 31 December 2017 to fully comply with Solvency II capital requirements

 

UK and European storms

In common with many other insurers in this market, the Company is experiencing claims arising from the storms and floods experienced in the UK and Europe at the end of 2015. We expect that reinsurance arrangements will limit the financial impact to between £2 million and £3 million.

 

Convertible Loan Note Instrument

On 21 December 2015 Gable announced the issue of a Convertible Loan Note Instrument with a term of three years under which Loan Notes may be issued up to a maximum aggregate value of £10 million. The Company issued Loan Notes amounting to £3.96m during 2015 and has no intention to issue any further Notes under the Instrument. 

 

Current Trading and Outlook

§ Momentum of high quality new business opportunities has continued into 2016

§ We continue to review our underwriting portfolio to ensure focus on profitability, core customers and strategic classes of business and have initiated a programme to review business which does not meet our underwriting criteria

§ We remain focused on delivering profitable underlying insurance results

 

Commenting, William Dewsall, Chief Executive of Gable, said:

"Gable produced another year of growth in the underlying business with a strong core underwriting performance which was achieved in challenging markets. The overall performance was impacted only at the year-end by the severe December storms and floods, and we were once again quick to respond to our customers' requirements in getting many businesses back in action following the storms, whilst Gable was also well protected through its reinsurance arrangements, limiting the ultimate financial impact. We remain focussed on delivering underwriting profits with a strong and growing cash position which has continued to increase by over 40% on 2014.

 

"I should like to thank those who supported Gable's December funding round which has ensured compliance under the transitional provisions of Solvency II.

"We are encouraged by the continued momentum in high quality new business that we have seen during the first quarter which give us confidence concerning the levels of profitable business that we can achieve during the 2016.

"We also note with interest that Allianz Risk Transfer AG based in Switzerland has recently announced that it intends to relocate its European headquarters to Liechtenstein at the end of 2016 pending regulatory approvals. We are delighted that it both endorses the excellent regulatory credentials of the FMA in Liechtenstein and brings another major European non-life insurance company into the country."

ENDS

Enquiries:

Gable Holdings Inc.

William Dewsall, Chief Executive

Michael Hirschfield, Group Finance Director

John Bick, Investor Relations

 

Tel: +44(0) 20 7337 7460

Zeus Capital Limited

Nicholas How, Corporate Finance

Adam Pollock, Corporate Broking

Tel: +44(0) 20 3829 5000

Haggie Partners LLP

Peter Rigby

Ned Ellison

Rob Tuttlebee

Tel : +44(0) 20 7562 4444

 

About Gable Holdings Inc.

 

Gable is a European non-life insurance company underwriting a comprehensive range of specialist policies for the commercial sectors in the UK, Denmark, France, Germany, Italy, Norway, Spain and Sweden. Gable benefits from a low-cost online underwriting platform and the Company has continued to successfully grow its business geographically whilst simultaneously exploiting a range of niche insurance segments which exist across the EU, which is delivered through the EU passporting mechanism. Gable Holdings Inc. is quoted on the London Stock Exchange's AIM market. For further information please visit www.gableholdings.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKKDPPBKDPNN
Date   Source Headline
30th Sep 20162:30 pmRNSHalf-year Report
16th Sep 20162:50 pmRNSUpdate re: delisting
12th Sep 20167:30 amRNSSuspension - Gable Holdings Inc.
12th Sep 20167:00 amRNSNOMAD and Suspension
12th Sep 20167:00 amRNSStrategic Restructuring and Intention to Delist
9th Sep 201611:40 amRNSBoard Changes
31st Aug 201612:06 pmRNSDirectorate Change
24th Aug 201611:28 amRNSResult of Meeting
24th Aug 20167:00 amRNSAGM Statement
1st Aug 20167:00 amRNSDirectorate Change
18th Jul 20167:30 amRNSRestoration - Gable Holdings Inc.
18th Jul 20167:00 amRNSSuspension of shares
15th Jul 201610:21 amRNSAnnual Report and Notice of Meeting
15th Jul 20167:00 amRNSFinal Results for the year ended 31 December 2015
1st Jul 20167:31 amRNSTemporary Suspension - Update re: Strategic Review
1st Jul 20167:30 amRNSSuspension - Gable Holdings Inc.
1st Jun 20163:49 pmRNSUpdate on Potential Related Party Transaction
25th May 20164:01 pmRNSTradingUpdate/Rel.PartyTransaction/Strat.Review
31st Mar 20167:00 amRNSTrading Update
29th Jan 20167:00 amRNSDirector/PDMR Shareholding
21st Dec 20157:01 amRNSFunding, trading update & rel. party transactions
10th Dec 201510:02 amRNSGable Holdings Inc. Board Appointment
10th Sep 20157:00 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSNotice of Results and Trading Update
11th Aug 201511:40 amRNSHolding(s) in Company
27th Jul 20157:00 amRNSBoard Appointment
16th Jul 20159:22 amRNSSwiss Re Quota Share Agreement
6th Jul 20157:00 amRNSChange of Adviser
23rd Jun 201512:27 pmRNSResult of AGM
3rd Jun 201512:43 pmRNSDirector/PDMR Shareholding
2nd Jun 20153:36 pmRNSAnnual Financial Report
28th May 20157:00 amRNSFinal Results
18th May 20159:53 amRNSNotice of Results
23rd Mar 20157:00 amRNSFirst Stage of New Italian Underwriting Programme
12th Feb 20153:21 pmRNSDirector/PDMR Shareholding
12th Feb 20157:00 amRNSTrading Update 2014 and Strong Outlook for 2015
11th Feb 20157:00 amRNSDirectorate Change
18th Dec 20147:56 amRNSReplacement RNS: Holding(s) in Company
18th Dec 20147:00 amRNSDirector/PDMR Shareholding
11th Nov 20147:00 amRNSNumis Appointed as Nomad and Broker
11th Nov 20147:00 amRNSNew Business Agreement
25th Sep 20147:00 amRNSNew Business - Norway
22nd Sep 20149:25 amRNSDirector/PDMR Shareholding
19th Sep 20144:30 pmRNSDirector/PDMR Shareholding
19th Sep 20142:00 pmRNSDirector/PDMR Shareholding
12th Sep 201411:02 amRNSDirector/PDMR Shareholding
11th Sep 20142:19 pmRNSDirector/PDMR Shareholding
11th Sep 20147:00 amRNSHalf Yearly Report
11th Sep 20147:00 amRNS£100m GWP New Business Agreement
5th Sep 201412:57 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.